SecFilingDex
424B5RNTXCIK 0001420565

Rein Therapeutics, Inc.

Prospectus supplement (424B5) filed .

Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.

Filing facts

Accession number
0001193125-25-168822
Filer
Rein Therapeutics, Inc.
Ticker
RNTX
CIK
0001420565
Form type
424B5
Form description
Prospectus supplement
Filed at
July 30, 2025
Filing size
87.9 KB
Last verified
August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.